AZD0754

BIOLOGICAL2 trials

Sponsors

AstraZeneca

Conditions

Hepatocellular CarcinomaMetastatic Prostate CancerProstate Cancer

Phase 1

Study of AZD0754 in Participants With Metastatic Prostate Cancer

RecruitingNCT06267729

AstraZenecaMetastatic Prostate Cancer

Start: 2024-03-12End: 2026-11-24Target: 60Updated: 2026-02-23

Unknown Phase

LTFU for All Cell and Gene Therapy Studies

Not yet recruitingNCT06194461

AstraZenecaHepatocellular Carcinoma, Prostate Cancer

Start: 2025-09-17End: 2041-11-29Target: 64Updated: 2025-06-27